Published in Biomed Rep on June 03, 2016
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum (2010) 18.82
ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol (2013) 4.36
Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract (2012) 4.11
Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med (2010) 3.24
Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res (2003) 3.07
Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet (2010) 1.69
Cutaneous manifestations of primary Sjögren's syndrome are underestimated. Clin Exp Rheumatol (2004) 1.50
Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res (2005) 1.50
Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res (2012) 1.48
Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy. J Invest Dermatol (1998) 1.41
[Multiple autoimmune syndromes]. Ann Med Interne (Paris) (1988) 1.26
Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. J Immunol (2010) 1.24
Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP. J Invest Dermatol (2010) 1.14
How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med (2013) 1.12
Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue. Genes Immun (2012) 1.09
Clinical profiles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol (2005) 1.07
A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol (2012) 1.06
Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune Dis (2012) 1.01
The multiple autoimmune syndromes. A clue for the autoimmune tautology. Clin Rev Allergy Immunol (2012) 0.95
Sjögren's syndrome at the crossroad of polyautoimmunity. J Autoimmun (2012) 0.92
Anticentromere antibodies (ACA): clinical distribution and disease specificity. Clin Exp Dermatol (1994) 0.92
Multiple autoimmune syndrome. Maedica (Buchar) (2010) 0.91
The genetics of vitiligo. J Invest Dermatol (2011) 0.89
Vitiligo prevalence study in Shaanxi Province, China. Int J Dermatol (2007) 0.89
[Epidemiology of skin diseases in 10,000 patients of pediatric age]. Bol Med Hosp Infant Mex (1977) 0.88
The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients. Arch Dermatol Res (2008) 0.88
Common immunogenetic profile in children with multiple autoimmune diseases: the signature of HLA-DQ pleiotropic genes. Autoimmunity (2012) 0.86
Prevalence of vitiligo and associated comorbidities in Korea. Yonsei Med J (2015) 0.84
The diagnosis and clinical significance of polyautoimmunity. Autoimmun Rev (2014) 0.82
Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study. Dermatology (2014) 0.81
Autoimmune vitiligo does not require the ongoing priming of naive CD8 T cells for disease progression or associated protection against melanoma. J Immunol (2014) 0.80
Commentary from the Editorial Board to Vitiligo: interplay between oxidative stress and immune system (Laddha et al.). Exp Dermatol (2013) 0.79
Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients. J Dermatol Sci (1996) 0.79
Simultaneous immunofluorescent labeling using anti-BrdU monoclonal antibody and a melanocyte-specific marker in formalin-fixed paraffin-embedded human skin samples. Appl Immunohistochem Mol Morphol (2012) 0.79
Thyroid-associated orbitopathy is linked to gastrointestinal autoimmunity. Clin Exp Immunol (2014) 0.79
Genetic analysis of 17 Y-STRs in a Mestizo population from the Central Valley of Mexico. Hum Biol (2014) 0.78
Association analysis revealed one susceptibility locus for vitiligo with immune-related diseases in the Chinese Han population. Immunogenetics (2015) 0.78
The molecular basis for the presence of two autoimmune diseases occurring simultaneously--preliminary observations based on computer analysis. Autoimmunity (2011) 0.78
Epitopes, avidity and IgG subclasses of tyrosine hydroxylase autoantibodies in vitiligo and alopecia areata patients. Br J Dermatol (2012) 0.77
Vitiligo patterns simulating autoimmune and rheumatic diseases. Lancet (1979) 0.77
Associations between TNF-α polymorphisms and susceptibility to rheumatoid arthritis and vitiligo: a meta-analysis. Genet Mol Res (2015) 0.77
Vitiligo, rheumatoid arthritis and pernicious anemia. J Dermatol (1993) 0.76
Poly-autoimmunity in patients with myasthenia gravis: A single-center experience. Autoimmunity (2015) 0.76